We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Jun 23
Data support that antibiotic aztreonam-avibactam (ATM-AVI) is effective and well-tolerated in treating infections caused by Gram-negative bacteria, with…
01 Jun 23
Abrysvo is a bivalent RSV prefusion F (RSVpreF) unadjuvanted vaccine that contains two preF proteins to optimise the…
01 Jun 23
In the trial, the number of new gadolinium-enhancing (GdE) T1-lesions was lowered by 89% and 79% in the…
01 Jun 23
The phase 2 study was evaluating upadacitinib 30mg alone and in combination (ABBV-599 high dose) in systemic lupus…
01 Jun 23
The scientists found that the disorder has an overactive version of the STAT4 protein, which controls inflammation and…
01 Jun 23
Cobitolimod, a TLR9 agonist, is currently undergoing evaluation in the global phase III programme, known as CONCLUDE, as…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
01 Jun 23
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing…
01 Jun 23
Researchers trained a computer model to understand the connections between thousands of genes—and pinpoint how those connections go…
31 May 23
The drug discovery partnership will make use of XtalPi’s integrated AI capabilities and robotics platform to design and…
31 May 23
In the late-stage trial, the prophylactic treatment with marstacimab showed a statistically significant and clinically relevant reduction in…